Linshom
MD - BaltimoreBiotechnology
Focus: Linshom is an early-stage biotechnology company focused on continuous predictive respiratory monitoring devices for post-surgical respiratory failure. Founded in 2024 and based in Baltimore, MD, the company is pre-revenue and in Series A funding stage.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
SERIES A
Open Jobs
0
About Linshom
AI assessmentNot HiringNo open roles listed right now. Follow Linshom to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Linshom Continuous Predictive Respiratory Monitoring
Post Surgical Respiratory FailureClinical Trials (1)
NCT06744790Advanced Prediction of Respiratory Depression Episode Using the Linshom Continuous Predictive Respiratory Sensor
N/AHelp build intelligence for Linshom
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.